• Friday, January 14: Pharmacological and Psychotherapy of Anxiety: When does CBT (or other modalities) need add-on pharmacotherapy?
  In this second part of a two-part series about the integration of pharmacotherapy with psychotherapy, the rationales for adding medications to psychotherapy for anxiety will be explored. Additionally, two special populations will be explored: (1) clients with co-occurring anxiety and depression, and (2) patients with co-occurring substance use disorder, in particular clients in partial or sustained recovery. Case examples will illustrate features of treatment plans utilizing specific pharmacotherapies.

Program Level: Intermediate

• Learning Objectives:

1. Enumerate at least three common general medical conditions which may cause clinical levels of anxiety via their pathophysiology.
2. Classify three pharmacological treatments for anxiety based on mechanism of action; describe an empirically validated psychotherapy that could be utilized with each pharmacological approach.
3. Rank-order anxiolytics from most safe to least safe to use with persons in recovery from substance use disorders.

  The Colorado Psychological Association is approved by the American Psychological Association to sponsor continuing education for psychologists. CPA maintains responsibility for this program and its contents.